S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

QGEN Qiagen NV

44.52

-0.01 (-0.02%)

After Hours

Last Updated: 10:02:25

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Qiagen NV Charts.

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Qiagen NV Charts.

Qiagen NV News

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
Friday 13 December 2024 (3 weeks ago) • Business Wire

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
Friday 6 December 2024 (4 weeks ago) • Business Wire

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
Thursday 28 November 2024 (1 month ago) • Business Wire

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Thursday 28 November 2024 (1 month ago) • GlobeNewswire Inc.

QIAGEN collaborates with McGill University to advance microbiome research
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Monday 4 November 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Tuesday 29 October 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Friday 11 October 2024 (3 months ago) • GlobeNewswire Inc.

QIAGEN N.V. to release results for Q3 2024 and hold webcast
Thursday 10 October 2024 (3 months ago) • GlobeNewswire Inc.

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
Tuesday 8 October 2024 (3 months ago) • GlobeNewswire Inc.

More Qiagen NV News Articles

Commonwealth Bank Of Aus...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions